NMS · Financial Statements

Rigel Pharmaceuticals, Inc. (RIGL) Financial Statements

$45.97 NMS: RIGL Market Cap $858.71M

Rigel Pharmaceuticals, Inc. most recently reported annual revenue of $294.0M, net profit of $367.0M. Revenue grew at an average annual rate of 22.0% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20212022202320242025
Revenue$149.0M$120.0M$117.0M$179.0M$294.0M
Operating Profit$-12.0M$-56.0M$-20.0M$24.0M$125.0M
Net Profit$-18.0M$-59.0M$-25.0M$17.0M$367.0M
EPS$-1.10$-3.40$-1.44$0.99$19.48
Op Margin-8.4%-46.2%-17.5%13.5%42.6%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$167.0M$134.0M$117.0M$164.0M$514.0M
Total Liabilities$137.0M$148.0M$146.0M$161.0M$122.0M
Cash$19.0M$24.0M$33.0M$57.0M$41.0M
Borrowings$31.0M$42.0M$61.0M$60.0M$53.0M

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$6.0M$-74.0M$-6.0M$31.0M$76.0M
Investing Cash Flow$-81.0M$72.0M$-19.0M$4.0M$-92.0M
Financing Cash Flow$63.0M$-13.0M$-2.0M$-12.0M$0
Net Cash Flow$-11.0M$6.0M$8.0M$24.0M$-16.0M
Free Cash Flow$5.0M$-74.0M$-21.0M$31.0M$76.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.01
EV / EBITDA9.06
FCF Yield9.10%
Quick Ratio1.79
Interest Coverage15.00
Return 1Y74.75%
Return 3Y189.92%
Return 5Y0.66%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
RIGL Overview RIGL Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.